Regulatory Mechanisms in Lymphatic Muscle Contraction

淋巴肌收缩的调节机制

• 批准号: 7657281
• 负责人: MARIAPPAN MUTHUCHAMY
• 金额: $ 10.04万
• 依托单位: TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-09-01 至 2012-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7657281
• 关键词: Actins; Address; Adrenergic Agonists; Affect; Bathing; Behavior; Binding; Blood Vessels; Bradykinin; Buffers; Calcium; Caliber; Cardiac; Cardiovascular system; Cells; Characteristics; Chest; Complement; Contractile Proteins; Data; Down-Regulation; Exhibits; Functional disorder; Gene Expression; Gene Knock-Out Model; Genes; Genomics; Goals; Immunoblotting; Immunofluorescence Immunologic; Immunoprecipitation; Isometric Contraction; Knock-out; Knockout Mice; Levosimendan; Lymphatic; Lymphatic vessel; Measurement; Measures; Mediating; Mesentery; Methods; Microfilaments; Molecular; Molecular Genetics; Monitor; Motor; Mus; Muscle; Muscle Contraction; Muscle function; Myosin Heavy Chains; Myosin Light Chain Kinase; Myosin Light Chains; Peptides; Pharmaceutical Preparations; Phosphorylation; Physiological; Preparation; Protein Isoforms; Proteins; Proteomics; RNA; Rattus; Regulation; Regulatory Element; Regulatory Pathway; Research; Role; Saline; Series; Signal Pathway; Skin; Small Interfering RNA; Smooth Muscle; Smooth Muscle Myosins; Striated Muscles; Students; Substance P; Temperature; Testing; Thick; Thick Filament; Thin Filament; Thoracic Duct; Tissues; Training; Transducers; Transfection; Transgenic Mice; Transgenic Model; Transgenic Organisms; Tropomyosin; Troponin; Troponin C; Tungsten; Vascular Smooth Muscle; Western Blotting; abstracting; base; caldesmon; calponin; career; genetic regulatory protein; kinase inhibitor; knock-down; knowledge base; lymphatic duct; mRNA Expression; mouse model; non-muscle myosin heavy chain-B; overexpression; pressure; promoter; research study; response; synthetic peptide; therapy development

DESCRIPTION (provided by applicant): My immediate career objectives are to develop a reputation for high quality research and to train graduate and postdoctoral students in the cardiovascular and lymphatic research field. My long-term career are to advance the level of understanding the regulatory mechanisms of lymphatic muscle contractility under normal and diseased/pathophysiological conditions. Lymphatic muscle exhibits strong/phasic contractions, much higher shortening velocities and different intracellular calcium dynamics. Unfortunately little information is known about the molecular mechanisms that are responsible for these unique characteristics. In this proposal we will use the available contractile protein gene knock out models or transgenic models with overexpression of contractile protein isoforms to test the central hypothesis remodeling of thick or thin filament proteins in the contractile apparatus of lymphatic muscle modulates its contractile dynamics through altering the calcium sensitivity and crossbridge activation mechanisms. The specific aims are: (1) To determine the functional roles of SM-B myosin heavy chain (MHC) in the phasic and tonic contraction of lymphatics, (2) To define the roles of tropomyosin in the thin filament-mediated contraction of lymphatics. We will use SM-B MHC knockout and SM-MHC/calponin double knockout mouse models. The vascular smooth muscle a-actin promoter will be to express striated muscle tropomyosin in lymphatic muscle. An adenoviral siRNA approach will be used knock down the smooth muscle a- and p-TM gene expression in lymphatics. We will isolated/cannulated vessels from iliac and thoracic duct lymphatics to study the contractile characteristics of lymphatics. Force and calcium measurements will be conducted in the lymphatic segment preparations (both intact and skinned) to determine the calcium sensitivity and cooperativity mechanisms of lymphatics. The contractile mechanisms of lymphatics are poorly understood and this study will significantly advance our knowledge of the basis for the lymphatic vessel function. These studies further advance my training lymphatic research using mouse models, which would allow me to develop and use genomic proteomic approaches to determine the signaling pathways that regulate lymphatic muscle function. (End of Abstract)

描述（由申请人提供）： 我的近期职业目标是建立高质量研究的声誉，并培养心血管和淋巴研究领域的研究生和博士后学生。我的长期职业生涯是提高对正常和疾病/病理生理条件下淋巴肌收缩性调节机制的理解水平。淋巴肌表现出强/阶段性收缩，更高的缩短速度和不同的细胞内钙动力学。不幸的是，关于这些独特特征的分子机制的信息知之甚少。在本研究中，我们将利用现有的收缩蛋白基因敲除模型或过表达收缩蛋白亚型的转基因模型来验证中心假设，即淋巴肌收缩器中的粗丝或细丝蛋白的重塑通过改变钙敏感性和横桥激活机制来调节其收缩动力学。具体目标是：（1）确定SM-B型肌球蛋白重链（MHC）在平滑肌的时相性和强直性收缩中的功能作用;（2）确定原肌球蛋白在平滑肌的稀薄收缩中的作用。我们将使用SM-B MHC敲除和SM-MHC/calponin双敲除小鼠模型。血管平滑肌α-肌动蛋白启动子将在淋巴肌中表达横纹肌原肌球蛋白。将使用腺病毒siRNA方法敲低动脉粥样硬化中的平滑肌a-和p-TM基因表达。我们将从髂、胸导管分支中分离出血管并插管，以研究分支的收缩特性。将在淋巴节段制备物（完整和去皮）中进行力和钙测量，以确定钙敏感性和粘附剂的协同机制。淋巴管收缩的机制知之甚少，这项研究将大大提高我们对淋巴管功能基础的认识。这些研究进一步推进了我使用小鼠模型进行的训练淋巴研究，这将使我能够开发和使用基因组蛋白质组学方法来确定调节淋巴肌功能的信号通路。 (End摘要）